{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:05:59Z","timestamp":1783094759069,"version":"3.54.6"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-024-11343-y","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T17:05:42Z","timestamp":1724173542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey"],"prefix":"10.1186","volume":"24","author":[{"given":"Kunle","family":"Rotimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde","family":"Fagbemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Omole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminu Ahmed","family":"Biambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo","family":"Ibinaiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azuka","family":"Iwegbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olabisi","family":"Ogunmola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibuzo","family":"Oguoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusola","family":"Oresanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"11343_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40264-015-0387-4","volume":"39","author":"HH Ampadu","year":"2016","unstructured":"Ampadu HH, Hoekman J, de Bruin ML, Pal SN, Olsson S, Sartori D, et al. Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the Rest of the World: analyses of spontaneous reports in VigiBase\u00ae. Drug Saf. 2016;39:335\u201345.","journal-title":"Drug Saf"},{"key":"11343_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2125.2006.02860.x","volume":"63","author":"JK Aronson","year":"2007","unstructured":"Aronson JK. Adverse drug reactions \u2013 no farewell to harms. Br J Clin Pharmacol. 2007;63:131\u20135.","journal-title":"Br J Clin Pharmacol"},{"key":"11343_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12913-019-4775-9","volume":"19","author":"R Adisa","year":"2019","unstructured":"Adisa R, Omitogun TI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019;19:926.","journal-title":"BMC Health Serv Res"},{"key":"11343_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","volume":"7","author":"AH Lavan","year":"2016","unstructured":"Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7:11\u201322.","journal-title":"Ther Adv Drug Saf"},{"key":"11343_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/0976-500X.110872","volume":"4","author":"DK Brahma","year":"2013","unstructured":"Brahma DK, Wahlang JB, Marak MD. Ch. Sangma M. Adverse drug reactions in the elderly. J Pharmacol Pharmacother. 2013;4:91\u20134.","journal-title":"J Pharmacol Pharmacother"},{"key":"11343_CR6","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0976-500X.120957","volume":"4","author":"J Sultana","year":"2013","unstructured":"Sultana J, Cutroneo P, Trifir\u00f2 G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4:S73\u20137.","journal-title":"J Pharmacol Pharmacother"},{"key":"11343_CR7","doi-asserted-by":"publisher","first-page":"e073777","DOI":"10.1136\/bmjopen-2023-073777","volume":"13","author":"AK Sendekie","year":"2023","unstructured":"Sendekie AK, Kasahun AE, Limenh LW, Dagnaw AD, Belachew EA. Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case\u2013control study in Ethiopia. BMJ Open. 2023;13:e073777.","journal-title":"BMJ Open"},{"key":"11343_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/21556660.2019.1566137","volume":"8","author":"MD G\u00fcner","year":"2019","unstructured":"G\u00fcner MD, Ekmekci PE. Healthcare professionals\u2019 pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8:13\u201320.","journal-title":"J Drug Assess"},{"key":"11343_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s40264-018-0681-z","volume":"41","author":"R van Eekeren","year":"2018","unstructured":"van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, et al. What future Healthcare professionals need to know about Pharmacovigilance: introduction of the WHO PV core curriculum for University teaching with focus on clinical aspects. Drug Saf. 2018;41:1003\u201311.","journal-title":"Drug Saf"},{"key":"11343_CR10","first-page":"1077","volume":"10","author":"W Srisuriyachanchai","year":"2022","unstructured":"Srisuriyachanchai W, Cox AR, Jarernsiripornkul N. Exploring Healthcare professionals\u2019 practices and attitudes towards monitoring and reporting of severe adverse drug reactions. Healthc (Basel). 2022;10:1077.","journal-title":"Healthc (Basel)"},{"key":"11343_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jonm.12310","volume":"24","author":"A De Angelis","year":"2016","unstructured":"De Angelis A, Colaceci S, Giusti A, Vellone E, Alvaro R. Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review. J Nurs Adm Manag. 2016;24:151\u201363.","journal-title":"J Nurs Adm Manag"},{"key":"11343_CR12","first-page":"e01283","volume":"17","author":"K Rotimi","year":"2022","unstructured":"Rotimi K, Aiden J, Dabes C, Maduka K, Oguche D, Itiola AJ, et al. Pharmacovigilance reporting during seasonal malaria chemoprevention campaign: findings from northern Nigeria. Sci Afr. 2022;17:e01283.","journal-title":"Sci Afr"},{"key":"11343_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jsps.2014.07.005","volume":"23","author":"MMM Abdel-Latif","year":"2015","unstructured":"Abdel-Latif MMM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015;23:154\u201361.","journal-title":"Saudi Pharm J"},{"key":"11343_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/0018578720910401","volume":"56","author":"I Ali","year":"2021","unstructured":"Ali I, Ahmad W, Ullah AR, Khan F, Ijaz M, Khan S, et al. Knowledge, attitude, and barriers toward ADRs reporting among Health-Care professionals at Tertiary Care Health settings in Peshawar, Pakistan: a web based study. Hosp Pharm. 2021;56:384\u201391.","journal-title":"Hosp Pharm"},{"key":"11343_CR15","doi-asserted-by":"publisher","first-page":"e0162563","DOI":"10.1371\/journal.pone.0162563","volume":"11","author":"JL NDiaye","year":"2016","unstructured":"NDiaye JL, Ciss\u00e9 B, Ba EH, Gomis JF, Ndour CT, Molez JF, et al. Safety of Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine plus Amodiaquine when delivered to children under 10 years of age by District Health Services in Senegal: results from a stepped-Wedge Cluster Randomized Trial. PLoS ONE. 2016;11:e0162563.","journal-title":"PLoS ONE"},{"key":"11343_CR16","unstructured":"World Health Organization. Seasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide. 2023. https:\/\/www.who.int\/publications-detail-redirect\/9789240073692. Accessed 5 Aug 2023."},{"key":"11343_CR17","volume-title":"Seasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Seasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2013."},{"key":"11343_CR18","unstructured":"Malaria Consortium. Malaria Consortium Project Brief: Reducing the malaria burden in Nigeria. 2021. https:\/\/www.malariaconsortium.org\/what-we-do\/projects\/102\/reducing-the-malaria-burden. Accessed 30 Mar 2023."},{"key":"11343_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s42269-023-01035-8","volume":"47","author":"K Rotimi","year":"2023","unstructured":"Rotimi K, Fagbemi B, Ibinaiye T, Aiden J, Gabriel V, Dabes C, et al. Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022. Bull Natl Res Centre. 2023;47:67.","journal-title":"Bull Natl Res Centre"},{"key":"11343_CR20","volume-title":"The Safety of Medicines in Public Health Programmes: Pharmacovigilance an essential tool","author":"World Health Organization, editor","year":"2006","unstructured":"World Health Organization, editor. The Safety of Medicines in Public Health Programmes: Pharmacovigilance an essential tool. Geneva: WHO [u.a.]; 2006."},{"key":"11343_CR21","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.4269\/ajtmh.22-0625","volume":"108","author":"MA Chang","year":"2023","unstructured":"Chang MA, Fouch\u00e9 B, LaFortune W, Holmes K, Rigodon J, Juin S, et al. Investigation of four cases of Stevens\u2013Johnson syndrome among participants in a Mass Drug Administration campaign with sulfadoxine-pyrimethamine and Primaquine in Haiti, 2020. Am J Trop Med Hyg. 2023;108:1140\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"11343_CR22","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600\u20137.","journal-title":"N Engl J Med"},{"key":"11343_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1186\/s12913-022-08264-z","volume":"22","author":"O Oresanya","year":"2022","unstructured":"Oresanya O, Phillips A, Okereke E, Ahmadu A, Ibinaiye T, Marasciulo M, et al. Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study. BMC Health Serv Res. 2022;22:871.","journal-title":"BMC Health Serv Res"},{"key":"11343_CR24","unstructured":"Malaria Consortium. Malaria Consortium\u2019s Seasonal Malaria Chemoprevention Programme: Philanthropy Report 2022. 2022. https:\/\/www.malariaconsortium.org\/media-download-file\/202305040928\/2022smcphilanthropyreport.pdf. Accessed 2 Nov 2023."},{"key":"11343_CR25","unstructured":"National Agency for Food and Drug Administration and Control. Handling Adverse Drug Reactions (ADRs) \u2013 NAFDAC. 2017. https:\/\/www.nafdac.gov.ng\/our-services\/pharmacovigilance-post-market-surveillance\/report-adverse-drug-reaction\/. Accessed 26 Dec 2022."},{"key":"11343_CR26","unstructured":"National Agency for Food and Drug Administration and Control. Pharmacovigilance\/Post Marketing Surveillance Newsletter. 2021. https:\/\/www.nafdac.gov.ng\/wp-content\/uploads\/Files\/Resources\/Pharmacovigilance_Newsletter\/2021-Vol.-14-No.-2-New-Developments-And-Activities-Of-The-National-Pharmacovigilance-Centre-In-The-Year-2020-And-2021.pdf. Accessed 5 Nov 2023."},{"key":"11343_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12936-023-04547-w","volume":"22","author":"N Ogbulafor","year":"2023","unstructured":"Ogbulafor N, Uhomoibhi P, Shekarau E, Nikau J, Okoronkwo C, Fanou NML, et al. Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach. Malar J. 2023;22:120.","journal-title":"Malar J"},{"key":"11343_CR28","unstructured":"World Health Organization. Service availability and readiness assessment (SARA): an annual monitoring system for service delivery: reference manual. World Health Organization; 2014."},{"key":"11343_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4097\/kjae.2013.64.5.402","volume":"64","author":"H Kang","year":"2013","unstructured":"Kang H. The prevention and handling of the missing data. Korean J Anesthesiol. 2013;64:402\u20136.","journal-title":"Korean J Anesthesiol"},{"key":"11343_CR30","unstructured":"A AA, Ys HNKAS, Pl B. L. Food safety knowledge, attitude, and practice toward compliance with abattoir laws among the abattoir workers in Malaysia. Int J Gen Med. 2016;9."},{"key":"11343_CR31","unstructured":"Ahmed N, Taneepanichskul S, Knowledge. Attitude and Practice of Dengue Fever Prevention among the people in Male, Maldives. J Health Res. 2008;22:33\u20137."},{"key":"11343_CR32","doi-asserted-by":"publisher","first-page":"101605","DOI":"10.1016\/j.eclinm.2022.101605","volume":"52","author":"M Taiwo","year":"2022","unstructured":"Taiwo M, Oyekenu O, Ekeh F, Dey AK, Raj A. Gender differences in work attendance among health care workers in Northern Nigeria during the COVID-19 pandemic. eClinicalMedicine. 2022;52:101605.","journal-title":"eClinicalMedicine"},{"key":"11343_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12960-021-00648-2","volume":"19","author":"SC Okoroafor","year":"2022","unstructured":"Okoroafor SC, Ahmat A, Osubor M, Nyoni J, Bassey J, Alemu W. Assessing the staffing needs for primary health care centers in Cross River State, Nigeria: a workload indicators of staffing needs study. Hum Resour Health. 2022;19:108.","journal-title":"Hum Resour Health"},{"key":"11343_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.12688\/f1000research.110039.2","volume":"11","author":"AI Oaiya","year":"2022","unstructured":"Oaiya AI, Tinuoye O, Olatawura L, Balarabe H, Abubakar H. Determining staffing needs for improving primary health care service delivery in Kaduna State. Nigeria F1000Res. 2022;11:429.","journal-title":"Nigeria F1000Res"},{"key":"11343_CR35","doi-asserted-by":"publisher","first-page":"1038062","DOI":"10.3389\/fpubh.2023.1038062","volume":"11","author":"WS Ajisegiri","year":"2023","unstructured":"Ajisegiri WS, Abimbola S, Tesema AG, Odusanya OO, Peiris D, Joshi R. We just have to help: Community health workers\u2019 informal task-shifting and task-sharing practices for hypertension and diabetes care in Nigeria. Front Public Health. 2023;11:1038062.","journal-title":"Front Public Health"},{"key":"11343_CR36","doi-asserted-by":"publisher","first-page":"6358624","DOI":"10.1155\/2018\/6358624","volume":"2018","author":"A Samulowitz","year":"2018","unstructured":"Samulowitz A, Gremyr I, Eriksson E, Hensing G. Brave men and emotional women: a theory-guided literature review on gender Bias in Health Care and gendered norms towards patients with Chronic Pain. Pain Res Manag. 2018;2018:6358624.","journal-title":"Pain Res Manag"},{"key":"11343_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/vaccines9020119","volume":"9","author":"R Shekhar","year":"2021","unstructured":"Shekhar R, Sheikh AB, Upadhyay S, Singh M, Kottewar S, Mir H, et al. COVID-19 Vaccine Acceptance among Health Care Workers in the United States. Vaccines. 2021;9:119.","journal-title":"Vaccines"},{"key":"11343_CR38","doi-asserted-by":"crossref","unstructured":"Muraya KW, Govender V, Mbachu C, Uguru NP, Molyneux S. Gender is not even a side issue\u2026it\u2019s a non-issue: career trajectories and experiences from the perspective of male and female healthcare managers in Kenya. Health Policy Plan. 2019;34:249\u201356.","DOI":"10.1093\/heapol\/czz019"},{"key":"11343_CR39","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.2196\/jmir.4127","volume":"17","author":"S Bidmon","year":"2015","unstructured":"Bidmon S, Terlutter R. Gender Differences in Searching for Health Information on the internet and the virtual patient-physician relationship in Germany: exploratory results on how men and women Differ and why. J Med Internet Res. 2015;17:e156.","journal-title":"J Med Internet Res"},{"key":"11343_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12875-016-0440-0","volume":"17","author":"AE Thompson","year":"2016","unstructured":"Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38.","journal-title":"BMC Fam Pract"},{"key":"11343_CR41","doi-asserted-by":"publisher","first-page":"638","DOI":"10.18203\/2319-2003.ijbcp20212070","volume":"10","author":"H Fatima","year":"2021","unstructured":"Fatima H, Subhani G, Mohsin M, Devi DN. A questionnaire based study-assessment of knowledge, attitude and practice of pharmacovigilance among health care professionals, pre and post educational intervention. Int J Basic Clin Pharmacol. 2021;10:638\u201342.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"11343_CR42","doi-asserted-by":"publisher","first-page":"8690546","DOI":"10.1155\/2019\/8690546","volume":"2019","author":"B Kassa Alemu","year":"2019","unstructured":"Kassa Alemu B, Biru TT. Health Care professionals\u2019 knowledge, attitude, and practice towards adverse drug reaction reporting and Associated Factors at selected public hospitals in Northeast Ethiopia: a cross-sectional study. Biomed Res Int. 2019;2019:8690546.","journal-title":"Biomed Res Int"},{"key":"11343_CR43","first-page":"165","volume":"40","author":"WA Adedeji","year":"2021","unstructured":"Adedeji WA, Adegoke AB, Fehintola FA. Adverse drug reactions reporting practice and associated factors among community health extension workers in public health facilities, Southwest, Nigeria. Pan Afr Med J. 2021;40:165.","journal-title":"Pan Afr Med J"},{"key":"11343_CR44","doi-asserted-by":"publisher","first-page":"e034553","DOI":"10.1136\/bmjopen-2019-034553","volume":"10","author":"K Gidey","year":"2020","unstructured":"Gidey K, Seifu M, Hailu BY, Asgedom SW, Niriayo YL. Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study. BMJ Open. 2020;10:e034553.","journal-title":"BMJ Open"},{"key":"11343_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3233\/JRS-130605","volume":"25","author":"A Osakwe","year":"2013","unstructured":"Osakwe A, Oreagba I, Adewunmi A, Adekoya A, Fajolu I. Impact of training on Nigerian healthcare professionals\u2019 knowledge and practice of pharmacovigilance. Int J risk Saf Med. 2013;25:219\u201327.","journal-title":"Int J risk Saf Med"},{"key":"11343_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.29252\/ijn.31.115.75","volume":"31","author":"M Boozari","year":"2018","unstructured":"Boozari M, Jalal E, Haghani H. Effects of Pharmacovigilance Training in the Elderly on the knowledge, attitude, and performance of nurses. Iran J Nurs. 2018;31:75\u201384.","journal-title":"Iran J Nurs"},{"key":"11343_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2023.03.005","author":"BP Solanke","year":"2023","unstructured":"Solanke BP, Birhare P, Sinha S, Dahiya N. A questionnaire-based study on the knowledge, attitude and practice on pharmacovigilance among pharmacists and nursing staff at teaching hospital. Med J Armed Forces India. 2023. https:\/\/doi.org\/10.1016\/j.mjafi.2023.03.005.","journal-title":"Med J Armed Forces India"},{"key":"11343_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12909-020-02084-7","volume":"20","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Sharma S, Bhasima R, Kunwor P, Adhikari B, Sapkota B. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC Med Educ. 2020;20:179.","journal-title":"BMC Med Educ"},{"key":"11343_CR49","unstructured":"Folasade O, Knowledge. Attitudes and Practices of Adverse Drug Reaction Reporting Among Nurses in a Tertiary Hospital in South West, Nigeria. 2018."},{"key":"11343_CR50","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00228-020-02862-8","volume":"76","author":"HM Haines","year":"2020","unstructured":"Haines HM, Meyer JC, Summers RS, Godman BB. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district. Eur J Clin Pharmacol. 2020;76:991\u20131001.","journal-title":"Eur J Clin Pharmacol"},{"key":"11343_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/bcp.15193","volume":"89","author":"R Kiguba","year":"2023","unstructured":"Kiguba R, Olsson S, Waitt C. Pharmacovigilance in low- and middle-income countries: a review with particular focus on Africa. Br J Clin Pharmacol. 2023;89:491\u2013509.","journal-title":"Br J Clin Pharmacol"},{"key":"11343_CR52","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/0018578720957968","volume":"56","author":"TA Adegbuyi","year":"2021","unstructured":"Adegbuyi TA, Fadare JO, Araromi EJ, Sijuade AO, Bankole I, Fasuba IK, et al. Assessment of Knowledge, attitude and practice of adverse drug reaction reporting among Healthcare professionals working in primary, secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria. Hosp Pharm. 2021;56:751\u20139.","journal-title":"Hosp Pharm"},{"key":"11343_CR53","doi-asserted-by":"publisher","first-page":"5728462","DOI":"10.1155\/2016\/5728462","volume":"2016","author":"LT Gurmesa","year":"2016","unstructured":"Gurmesa LT, Dedefo MG. Factors affecting adverse drug reaction reporting of Healthcare professionals and their knowledge, attitude, and practice towards ADR Reporting in Nekemte Town, West Ethiopia. Biomed Res Int. 2016;2016:5728462.","journal-title":"Biomed Res Int"},{"key":"11343_CR54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/0976-9668.210014","volume":"8","author":"S Ganesan","year":"2017","unstructured":"Ganesan S, Sandhiya S, Reddy KC, Subrahmanyam DK, Adithan C. The impact of the Educational intervention on knowledge, attitude, and practice of pharmacovigilance toward adverse drug reactions reporting among Health-Care professionals in a Tertiary Care Hospital in South India. J Nat Sci Biol Med. 2017;8:203\u20139.","journal-title":"J Nat Sci Biol Med"},{"key":"11343_CR55","first-page":"634","volume":"38","author":"A Olowofela","year":"2021","unstructured":"Olowofela A, Fourrier-R\u00e9glat A, Isah A. Impact of an Educational intervention on adverse drug reaction reporting in Tertiary hospitals in South-South Nigeria. West Afr J Med. 2021;38:634\u201345.","journal-title":"West Afr J Med"},{"key":"11343_CR56","doi-asserted-by":"publisher","first-page":"e0200810","DOI":"10.1371\/journal.pone.0200810","volume":"13","author":"YK Avong","year":"2018","unstructured":"Avong YK, Jatau B, Gurumnaan R, Danat N, Okuma J, Usman I, et al. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV\/AIDS, Tuberculosis and Malaria: a prospective cohort study. PLoS ONE. 2018;13:e0200810.","journal-title":"PLoS ONE"},{"key":"11343_CR57","doi-asserted-by":"publisher","first-page":"e0227712","DOI":"10.1371\/journal.pone.0227712","volume":"15","author":"SS Nadew","year":"2020","unstructured":"Nadew SS, Beyene KG, Beza SW. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia. PLoS ONE. 2020;15:e0227712.","journal-title":"PLoS ONE"},{"key":"11343_CR58","first-page":"FC09","volume":"11","author":"GQ Othman","year":"2017","unstructured":"Othman GQ, Ibrahim MIM, Alshakka M, Ansari M, Al-Qadasi F, Halboup AM. Knowledge and perception about Pharmacovigilance among Pharmacy students of universities in Sana\u2019a Yemen. J Clin Diagn Res. 2017;11:FC09\u201313.","journal-title":"J Clin Diagn Res"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11343-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-11343-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11343-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T18:05:20Z","timestamp":1724177120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-11343-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11343"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-11343-y","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the state ministry of health of the various states where the study took place. Also, ethical approval for the SMC project was granted by the National Health Research Ethics Committee (NHREC) in Nigeria. Data were used in accordance with the NHREC\u2019s ethics standards. Informed consent was obtained from all survey participants before data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"952"}}